Rekrutierung

Eingeschlossene Patienten: 23.474 (Stand 07. April 2025)
Amgevita® (Adalimumab)249
Benepali® (Etanercept)1273
Cimzia® (Certolizumab)1049
Enbrel® (Etanercept)2878
Erelzi® (Etanercept)596
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)15
Hulio® (Adalimumab)290
Humira® (Adalimumab)2912
Hyrimoz® (Adalimumab)264
Idacio® (Adalimumab)69
Imraldi® (Adalimumab)245
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)170
Kevzara® (Sarilumab)231
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)101
Olumiant® (Baricitinib)554
Orencia® (Abatacept)996
Remicade® (Infliximab)762
Remsima® (Infliximab)27
Rinvoq® (Upadacitinib)329
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1379
Ruxience® (Rituximab)1
Simponi® (Golimumab)479
Truxima® (Rituximab)5
Tyenne® (Tocilizumab)57
Xeljanz® (Tofacitinib)403
Yuflyma® (Adalimumab)56
Zessly® (Infliximab)2
Kontrollen6488